These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 26059298)

  • 21. Synthetic gene networks in plant systems.
    Junker A; Junker BH
    Methods Mol Biol; 2012; 813():343-58. PubMed ID: 22083753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression profiling and bioinformatics analysis of gastric carcinoma.
    Liu N; Liu X; Zhou N; Wu Q; Zhou L; Li Q
    Exp Mol Pathol; 2014 Jun; 96(3):361-6. PubMed ID: 24589858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retropath: automated pipeline for embedded metabolic circuits.
    Carbonell P; Parutto P; Baudier C; Junot C; Faulon JL
    ACS Synth Biol; 2014 Aug; 3(8):565-77. PubMed ID: 24131345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery.
    Wroblewska L; Kitada T; Endo K; Siciliano V; Stillo B; Saito H; Weiss R
    Nat Biotechnol; 2015 Aug; 33(8):839-41. PubMed ID: 26237515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.
    Won J; Yim J; Kim TK
    FASEB J; 2002 Dec; 16(14):1943-5. PubMed ID: 12368233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of expression of the ubiquitous transcription factor cAMP response element-binding protein (CREB) and compensatory overexpression of the activator CREMtau in the human adrenocortical cancer cell line H295R.
    Groussin L; Massias JF; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2000 Jan; 85(1):345-54. PubMed ID: 10634409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer genomics: small RNAs with big impacts.
    Meltzer PS
    Nature; 2005 Jun; 435(7043):745-6. PubMed ID: 15944682
    [No Abstract]   [Full Text] [Related]  

  • 28. [RNA interference (RNAi) and its therapeutic potential in cancer].
    Vázquez-Vega S; Contreras-Paredes A; Lizano-Soberón M; Amador-Molina A; García-Carrancá A; Sánchez-Suárez LP; Benítez-Bribiesca L
    Rev Invest Clin; 2010; 62(1):81-90. PubMed ID: 20415062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional transcriptomics: an experimental basis for understanding the systems biology for cancer cells.
    Schäfer R; Tchernitsa OI; Györffy B; Serra V; Abdul-Ghani R; Lund P; Sers C
    Adv Enzyme Regul; 2007; 47():41-62. PubMed ID: 17335873
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthetic biology devices for in vitro and in vivo diagnostics.
    Slomovic S; Pardee K; Collins JJ
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14429-35. PubMed ID: 26598662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene regulation by transcription factors and microRNAs.
    Hobert O
    Science; 2008 Mar; 319(5871):1785-6. PubMed ID: 18369135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA expression and function in cancer.
    Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
    Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein.
    Xiong J; Du Q; Liang Z
    Oncogene; 2010 Sep; 29(35):4980-8. PubMed ID: 20562918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs and lymphomagenesis: a functional review.
    Lawrie CH
    Br J Haematol; 2013 Mar; 160(5):571-81. PubMed ID: 23205669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reconfigurable hybrid interface for molecular marker diagnostics and in-situ reporting.
    Ehrhardt K; Guinn MT; Quarton T; Zhang MQ; Bleris L
    Biosens Bioelectron; 2015 Dec; 74():744-50. PubMed ID: 26210472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In silico implementation of synthetic gene networks.
    Marchisio MA
    Methods Mol Biol; 2012; 813():3-21. PubMed ID: 22083733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engineering molecular circuits using synthetic biology in mammalian cells.
    Wieland M; Fussenegger M
    Annu Rev Chem Biomol Eng; 2012; 3():209-34. PubMed ID: 22468602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of melanoma-related microRNAs expression during the spontaneous regression of cutaneous melanomas in MeLiM pigs.
    Baco M; Chu CY; Bouet S; Rogel-Gaillard C; Bourneuf E; Le Provost F; Chu CY; Vincent-Naulleau S
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):668-70. PubMed ID: 24661544
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of downstream genes on synthetic genetic circuits.
    Moriya T; Yamamura M; Kiga D
    BMC Syst Biol; 2014; 8 Suppl 4(Suppl 4):S4. PubMed ID: 25521010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational Re-design of Synthetic Genetic Oscillators for Independent Amplitude and Frequency Modulation.
    Tomazou M; Barahona M; Polizzi KM; Stan GB
    Cell Syst; 2018 Apr; 6(4):508-520.e5. PubMed ID: 29680377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.